Efficacy and its predictor in microwave ablation for severe secondary hyperparathyroidism in patients undergoing haemodialysis

被引:21
作者
Diao, Zongli [1 ]
Liu, Xu [1 ]
Qian, Linxue [2 ]
Liu, Jing [1 ]
Liu, Sha [1 ]
Liu, Wenhu [1 ]
机构
[1] Capital Med Univ, Beijing Friendship Hosp, Dept Nephrol, 95 Yong An Rd, Beijing 100050, Peoples R China
[2] Capital Med Univ, Beijing Friendship Hosp, Dept Ultrasound, Beijing, Peoples R China
基金
中国国家自然科学基金;
关键词
Efficacy; microwave ablation; parathyroidectomy; predictor; secondary hyperparathyroidism; CHRONIC KIDNEY-DISEASE; PARATHYROID-HORMONE; DIALYSIS PATIENTS; SUBTOTAL PARATHYROIDECTOMY; RADIOFREQUENCY ABLATION; LASER-ABLATION; SURVIVAL; GUIDELINES; MANAGEMENT; CARCINOMA;
D O I
10.1080/02656736.2016.1194485
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Microwave ablation (MWA) can be used to treat severe secondary hyperparathyroidism; however, its efficacy and the predictor of its efficacy are unclear. In this retrospective study we determined the predictor of efficacy of MWA and compared the efficacy of MWA and parathyroidectomy. Materials and methods: Patients with severe secondary hyperparathyroidism who had received MWA or parathyroidectomy were enrolled in the study. Participants with MWA were divided into response and no response groups based on efficacy. Possible predictors were analysed using logistic regression to determine efficacy predictors. The participants were divided into MWA and parathyroidectomy groups, and the efficacy (including rates of achieving recommended goals for intact parathyroid hormone (iPTH), calcium, and phosphorus levels) were compared between the two groups. Results: Thirty-one participants were enrolled for predictor analysis. Only baseline iPTH level predicted efficacy (OR 0.997, P = 0.018). The optimal threshold value of iPTH for predicting efficacy was 1493.5 pg/mL. To compare efficacy, 30 patients were enrolled in MWA (18/30) and parathyroidectomy (12/30) groups. The rates of achieving recommended goals for iPTH levels varied between 0 and 60%; a significant difference was found between the groups at 5 months (P = 0.01). However, in the parathyroidectomy group, the iPTH level and rate of iPTH <124 pg/mL (lower limit of target range) were significantly lower than in the MWA group after treatment (40-75% versus 0-16.7%). Conclusion: Baseline iPTH level is a good predictor of MWA efficacy for severe secondary hyperparathyroidism; parathyroidectomy is more effective for severe secondary hyperparathyroidism than MWA.
引用
收藏
页码:614 / 622
页数:9
相关论文
共 50 条
  • [41] Cost-Effectiveness of Cinacalcet Hydrochloride for Hemodialysis Patients With Severe Secondary Hyperparathyroidism in Japan
    Komaba, Hirotaka
    Moriwaki, Kensuke
    Goto, Shunsuke
    Yamada, Shunsuke
    Taniguchi, Masatomo
    Kakuta, Takatoshi
    Kamae, Isao
    Fukagawa, Masafumi
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2012, 60 (02) : 262 - 271
  • [42] Efficacy and Safety of Etelcalcetide in Hemodialysis Patients with Moderate to Severe Secondary Hyperparathyroidism
    Monciino, Paola
    Magagnoli, Lorenza
    Fasulo, Eliana
    Frittoli, Michela
    Leotta, Chiara
    Pham, Hoang Nhat
    Stucchi, Andrea
    Ciceri, Paola
    Galassi, Andrea
    Cozzolino, Mario
    KIDNEY AND DIALYSIS, 2022, 2 (03): : 482 - 494
  • [43] The efficacy and safety of microwave ablation in patients with retroperitoneal metastases
    Wei, Zhigang
    Ye, Xin
    Yang, Xia
    Zheng, Aimin
    Huang, Guanghui
    Dong, Shenming
    Li, Wenhong
    Wang, Jiao
    Han, Xiaoying
    Meng, Min
    Ni, Yang
    INTERNATIONAL JOURNAL OF HYPERTHERMIA, 2018, 34 (07) : 1053 - 1060
  • [44] Surgical Attitude in Patients with Secondary Hyperparathyroidism Undergoing Dialysis
    Bratucu, M. N.
    Garofil, N. D.
    Radu, P. A.
    Paic, V.
    Zurzu, M.
    Goleanu, V.
    Popa, F.
    Strambu, V.
    Straja, D. N.
    CHIRURGIA, 2015, 110 (05) : 418 - 424
  • [45] Survival after parathyroidectomy in chronic hemodialysis patients with severe secondary hyperparathyroidism
    Diana Moldovan
    Simona Racasan
    Ina Maria Kacso
    Crina Rusu
    Alina Potra
    Cosmina Bondor
    Ioan Mihai Patiu
    Mirela Gherman-Căprioară
    International Urology and Nephrology, 2015, 47 : 1871 - 1877
  • [46] A short-term non-randomized controlled study of ultrasound-guided microwave ablation and parathyroidectomy for secondary hyperparathyroidism
    Zhao, Junfeng
    Qian, Linxue
    Teng, Changsheng
    Yu, Mingan
    Liu, Fangyi
    Liu, Yujiang
    Tan, Xiaoqu
    Li, Jianming
    INTERNATIONAL JOURNAL OF HYPERTHERMIA, 2021, 38 (01) : 1558 - 1565
  • [47] Complications encountered in the treatment of primary and secondary hyperparathyroidism with microwave ablation - a retrospective study
    Wei, Ying
    Peng, Li-Li
    Zhao, Zhen-Long
    Li, Yan
    Yu, Ming-An
    INTERNATIONAL JOURNAL OF HYPERTHERMIA, 2019, 36 (01) : 1263 - 1270
  • [48] Paricalcitol versus cinacalcet plus low-dose vitamin D therapy for the treatment of secondary hyperparathyroidism in patients receiving haemodialysis: results of the IMPACT SHPT study
    Ketteler, Markus
    Martin, Kevin J.
    Wolf, Myles
    Amdahl, Michael
    Cozzolino, Mario
    Goldsmith, David
    Sharma, Amit
    Marx, Steven
    Khan, Samina
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 (08) : 3270 - 3278
  • [49] The Effects of Parathyroidectomy vs Medical Treatments for Secondary Hyperparathyroidism in Patients Undergoing Dialysis: A Meta-Analysis
    Song, Zhixing
    Wu, Christopher
    Wang, Rongzhi
    Gillis, Andrea
    Fazendin, Jessica
    Lindeman, Brenessa
    Chen, Herbert
    ENDOCRINE PRACTICE, 2024, 30 (06) : 569 - 576
  • [50] Observation of the efficacy of parathyroidectomy for secondary hyperparathyroidism in hemodialysis patients: a retrospective study
    Qiu, Wenqiang
    Zhou, Ge
    BMC SURGERY, 2023, 23 (01)